 |
 |
Eli Lilly ties up with Lupin to push diabetes drug sales
29 July 2011
|
|
|
|
Jhunjhunwala reduces stake in Lupin
20 July 2011
|
|
|
Lupin promoters to sell domestic operations: unconfirmed reports
18 July 2011
|
| | |
|
|
Lupin signs agreement with Abott Laboratories and others for Fenofibrate
27 April 2011
|
|
|
Lupin in pact to supply TB drug to Brazil
05 January 2011
|
|
|
Lupin net profit up 40 per cent in Q4
05 May 2010
|
|
|
Lupin’s sleep disorder drug gets USFDA nod
22 March 2010
|
|
|
Lupin receives US FDA approval for perindopril erbumine tablets
29 January 2010
|
|
|
Lupin settles dispute with Forest Labs over Namenda
22 December 2009
|
|
|
Impressive Q2 results see Lupin net surge 38 per cent to Rs160 crore
27 October 2009
|
|
|
Lupin buys US rights for cholesterol drug Antara
29 September 2009
|
|
|
Lupin announces acquisition of worldwide rights for its nasal spray, AllerNaze
01 July 2009
|
|
|
Lupin reaches settlement with Wyeth on patented drug
13 May 2009
|
|
|
Pfizer brings patent infringement suits against Sun, Lupin, Wockhardt
06 May 2009
|
|
|
Divakar Kaza rejoins Lupin as president, HR
12 December 2008
|
|
|
Eli Lilly sues Lupin, Aurobindo for patent infringement
03 December 2008
|
|
|
US FDA observations not to affect drug sales: Lupin
14 November 2008
|
|
|
Lupin acquires majority stake in South Africa's Pharma Dynamics
18 September 2008
|
|
|
Lupin acquires stake in Australian pharma firm Generic Health
21 August 2008
|
|
|
Lupin in marketing alliance with Forest for asthma product
19 August 2008
|
|
|
Lupin Ltd, Sun Pharma and Dr Reddy's get US FDA approval for generic Depakote delayed-release tablets
31 July 2008
|
|
|
Lupin enter Europe with acquisition of German pharma marketing agency Hormosan
30 July 2008
|
|
|
Lupin
gets €20 million from patent deal
13 October 2007
|
|
|
Lupin
acquires Japan''s Kyowa Pharmaceutical
10 October 2007
|
|
|
Lupin
acquires drugs intermediates manufacturer Rubamin Laboratories
28 September 2007
|
|
|
Lupin
to invest Rs200 crore in new plant, capacity addition
10 August 2007
|
|
|
Lupin gets DCGI nod for phase II and III clinical trials of herbal psoriasis drug
19 July 2007
|
|
|
Lupin receives tentative US FDA approval for anti-psychotic drug Ziprasidone
21 May 2007
|
|
|
Lupin gets USFDA approval for paediatric Suprax oral suspension
12 April 2007
|
|
|
Lupin sells part rights of 'perindopril' to French firm for Rs115 crore
07 April 2007
|
|
|
Lupin gets marketing approval for cefpodoxime proxetil in France
13 March 2007
|
|
|
Lupin awarded tentative US FDA approval for sertraline
02 January 2007
|
|
|
Lupin
gets US FDA approval for Meloxicam
20 July 2006
|
|
|
Lupin to acquire 51-per cent stake in Dafra
25 May 2006
|
|
|
Lupin gets US FDA approval for Cefdinir
24 May 2006
|
|
|
US FDA approves Lupin's cefprozil suspension, Orchid's tablets
20 December 2005
|
|
|
Lupin
places $100-million FCCB
07 December 2005
|
|
|
Lupin
receives US FDA approval for Cephalexin capsules
01 December 2005
|
|
|
Lupin
receives IND approval from DCGI for Desoris LLL-3348
28 November 2005
|
|
|
FIIs
hike stake in Lupin, Cadila Healthcare, Aurobindo Pharma
20 October 2003
|
|
|
Lupin
to restructure board; to licence out new chemical entity
13 October 2003
|
|
|
Lupin
promoter D B Gupta to sell 12.5% stake to Newbridge
10 July 2003
|
|
|
Citigroup
to finalise Rs 300-cr equity investment deal in Lupin
09 May 2003
|
|
|
Lupin turns to cephalosporins and cardiovasculars for
growth
22 November 1999
|
